HKND:NYE-Humankind Benefit Corporation - Humankind US Stock ETF (USD)

ETF | Others |

Last Closing

USD 30.5996

Change

0.00 (0.00)%

Market Cap

USD 0.13B

Volume

60.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

N/A

USD 65.72B
JEPI JPMorgan Equity Premium Income..

N/A

USD 33.68B
DFAC Dimensional U.S. Core Equity 2..

N/A

USD 27.49B
DTB DTB

N/A

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

N/A

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 23.09B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 20.81B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 11.25B
DFUV Dimensional US Marketwide Valu..

N/A

USD 10.54B
DFAT Dimensional U.S. Targeted Valu..

N/A

USD 9.93B

ETFs Containing HKND

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.59% 63% D 63% D
Dividend Return 0.34% 27% F 19% F
Total Return 4.93% 62% D 60% D-
Trailing 12 Months  
Capital Gain 11.97% 57% F 60% D-
Dividend Return 0.81% 12% F 8% B-
Total Return 12.78% 54% F 54% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.94% 55% F 44% F
Dividend Return 1.81% 52% F 36% F
Total Return 0.87% 45% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 6.64% 66% D+ 88% B+
Risk Adjusted Return 27.25% 53% F 50% F
Market Capitalization 0.13B 68% D+ 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.